


Healthcare Industry News: HIV/AIDS
News Release - November 13, 2017
Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease
Source: Theravance Biopharma
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
